Jai Bhagwan Sharma*
Medical Oncology, H.O.D. and Senior Consultant, Action Cancer Hospital, New Delhi, India
*Corresponding Author: Jai Bhagwan Sharma, Medical Oncology, H.O.D. and Senior Consultant, Action Cancer Hospital, New Delhi, India.
Received: July 22, 2020; Published: July 30, 2020
Breast cancer remains the most frequently diagnosed cancer in women and, despite significant improvements in treatment, it remains the second leading cause of death from cancer.
Keywords: Epithelial-Mesenchymal Transition (EMT); Mesenchymal-Epithelial Transition (MET); Eribulin
Citation: Jai Bhagwan Sharma. “Reversing Phenotype from Epithelial-Mesenchymal Transition (EMT) to Mesenchymal-Epithelial Transition (MET) with Eribulin: Case Report". Acta Scientific Cancer Biology 4.8 (2020): 27-30.
Copyright: © 2020 Jai Bhagwan Sharma. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.